Sample Sizes Based on the Log-Rank Statistic in Complex Clinical Trials
From MaRDI portal
Publication:118080
DOI10.2307/2531910zbMATH Open0707.62262OpenAlexW2327667520WikidataQ52570205 ScholiaQ52570205MaRDI QIDQ118080FDOQ118080
Authors: Edward Lakatos, Edward Lakatos 
Publication date: March 1988
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2531910
Recommendations
- A Sample Size Formula for the Supremum Log‐Rank Statistic
- Tests for comparing estimated survival functions
- Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification
- Sample-size formula for clustered survival data using weighted log-rank statistics
- Sample size and power for the weighted log‐rank test and Kaplan‐Meier based tests with allowance for nonproportional hazards
noncompliancecomplex clinical trialslog-rank statisticMarkov processnonproportional hazardssample sizestaggered entryTarone-Ware class
Cited In (29)
- Calculation of Sample Size in Survival Trials: The Impact of Informative Noncompliance
- Designing a phase-III time-to-event clinical trial using a modified sample size formula and Poisson-Gamma model for subject accrual that accounts for the lag in site initiation using the PERT distribution
- Nonparametric Estimation of Duration of Accrual and Total Study Length for Clinical Trials
- Sample size calculation for two‐arm trials with time‐to‐event endpoint for nonproportional hazards using the concept of Relative Time when inference is built on comparing Weibull distributions
- Sample size calculation for clustered survival data under subunit randomization
- A note on variance estimation in the Cox proportional hazards model
- A comparison of the constant piecewise weighted logrank and Fleming-Harrington tests
- A simple procedure to estimate the optimal sample size in case of conjunctive coprimary endpoints
- The Influence of Biostatistics at the National Heart, Lung, and Blood Institute
- Adaptive designs for the one-sample log-rank test
- Assurance methods for designing a clinical trial with a delayed treatment effect
- Complex survival trial design by the product integration method
- Design and monitoring of survival trials in complex scenarios
- Sequential trials in the context of competing risks: concepts and case study, with R and SAS code
- Sample size selection in clinical trials when population means are subject to a partial order: one-sided ordered alternatives
- Sample-Size Formula for the Proportional-Hazards Regression Model
- Sample size calculation for the combination test under nonproportional hazards
- Novel application of a discrete time-to-event model for randomized oral immunotherapy clinical trials with repeat food challenges
- Sample size calculation for cluster randomization trials with a time-to-event endpoint
- Sample size calculation for the log-rank tests for multi-arm trials with a control
- A Sample Size Formula for the Supremum Log‐Rank Statistic
- Sample size calculation for rank tests comparing \(K\) survival distributions
- Data monitoring in complex clinical trials: Which treatment is better?
- Cross-product ratio calculation under different sampling schemes in clinical trials -- case study of the CYP-GUIDES trial
- nphPower
- The effect of grouping on the power of the Mantel-Haenszel test for the comparison of survival rates
- Minimum size survival analysis sampling plans for comparing multiple treatment groups to a single control group
- Sample size calculation for the proportional hazards model with a time-dependent covariate
- Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification
This page was built for publication: Sample Sizes Based on the Log-Rank Statistic in Complex Clinical Trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q118080)
